Noam Danenberg insider trades: Wize Pharma (WIZP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Noam reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 9, 2021 | WIZP | ↑ Buy | 2,916,667 | $0.12 | $350K | Direct | Mar 11, 2021 (2d) |
| Apr 21, 2019 | WIZP | ↑ Buy | 125,000 | $1.00 | $125K | Direct | Apr 23, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Noam Danenberg's insider trades
Noam Danenberg is Chief Executive Officer at Wize Pharma (WIZP). Since Apr 21, 2019, Noam has reported 2 open-market purchases worth $475K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (3 filings), option exercises (2 filings), grants and awards (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every WIZP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.